<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        226-368-20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2020
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ACRETIN C 1.2% + 0.025 % GEL
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CLINDAMYCIN PHOSPHATE,TRETINOIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1.2,0.025
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Topical
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Gel
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Tube
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        18
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        33.80
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jamjoom Pharmaceuticals Factory Company" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 394]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            JAMJOOM PHARMACEUTICALS CO. LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory  Company
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Acretin C&trade; Gel contains the active substances clindamycin and tretinoin.<br />Clindamycin is an antibiotic. It limits the growth of bacteria associated with<br />acne and the inflammation caused by these bacteria.<br />Tretinoin normalizes the growth of superficial skin cells and causes normal<br />shedding of the cells that clog the hair follicles in areas with acne. This<br />prevents the build-up of sebum and the formation of early acne lesions<br />(blackheads and whiteheads).<br />These active substances are more effective when combined than when used<br />separately.<br />Acretin C&trade; Gel is used on the skin to treat acne in patients 12 years and older.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; If you are allergic to clindamycin, tretinoin, or any of the other ingredients of<br />this medicine (listed in section 6).<br />&bull; If you are allergic to lincomycin.<br />&bull; If you have a chronic inflammatory bowel disease<br />(e.g. Crohn&rsquo;s disease or ulcerative colitis).<br />&bull; If you have a history of colitis with past antibiotic use which is characterised<br />by prolonged or significant diarrhoea or abdominal cramps.<br />&bull; If you or a member of your family have ever suffered from skin cancer.<br />&bull; If you are suffering from acute eczema which is characterised by inflamed,<br />red, dry and scaly skin.<br />&bull; If you are suffering from rosacea, a skin disease which affects the face and is<br />characterised by redness, pimples and peeling.<br />&bull; If you are suffering from other acute inflammatory conditions of the skin<br />(e.g. folliculitis), especially around the mouth (perioral dermatitis).<br />&bull; If you are suffering from certain special forms of acne vulgaris characterized<br />by pustular and deep cystic nodular acne lesions (acne conglobata and acne<br />fulminans).<br />If any of the above applies to you, do not use this medicine and talk to your<br />doctor.<br />Warnings and precautions<br />&bull; Avoid contact of this medicine with the mouth, eyes, mucous membranes and<br />with abraded or eczematous skin. Be careful when applying to sensitive areas<br />of skin. In case of accidental contact with the eyes, rinse with plenty of<br />lukewarm water.<br />&bull; You should not use Acretin C&trade; if you are pregnant, especially during the first<br />three months of the pregnancy. If you are a woman of childbearing potential,<br />you should not use Acretin C&trade; unless you are using contraception (see also<br />section &ldquo;Pregnancy, breast-feeding and fertility&rdquo;).<br />&bull; If prolonged or significant diarrhoea or abdominal cramps occur, stop using<br />this medicine and talk to your doctor immediately.<br />&bull; If you have atopic eczema (chronic, itching inflammation of the skin), please<br />talk to your doctor before using this medicine.<br />&bull; Exposure to natural or artificial light (such as a sunlamp) should be avoided.<br />This is because this medicine may make your skin more sensitive to sunburn<br />and other adverse effects of the sun.<br />An effective sunscreen with Sun Protection Factor (SPF) of at least 30 and<br />protective clothing (such as a hat) should be used any time you are outside.<br />If nevertheless your face becomes sunburnt, stop medication until your skin<br />has healed.<br />&bull; Talk to your doctor in case an acute inflammation of the skin occurs when<br />using this medicine.<br />&bull; Acretin C&trade; should not be applied at the same time as other preparations used<br />on the skin including cosmetics (see also section &ldquo;Other medicines and<br />Acretin C&trade;&rdquo;).</p><p>Other medicines and Acretin C&trade;<br />Please tell your doctor or pharmacist if you are taking or have recently taken<br />or might take any other medicines. This includes medicines that you buy<br />without a prescription or herbal medicines. This is because Acretin C&trade; can<br />affect the way some other medicines work. Also some other medicines can<br />affect the way Acretin C&trade; works.<br />If you have used any preparations that contain sulphur, salicylic acid, benzoyl<br />peroxide or rescinol or any chemical abrasives; you will need to wait until the<br />effect of those have subsided until you start using this medicine. Your doctor<br />will tell you when you can start using Acretin C&trade;.<br />Do not use medicated soaps cleansers or scrubbing solutions with strong<br />drying effect during treatment with Acretin C&trade;. You should be careful when<br />using the following that may have a drying effect: abrasive soaps, soaps and<br />cosmetics and products with high concentrations of alcohol, astringents,<br />spices or lime.<br />You should ask your doctor for advice before using this medicine together<br />with other medicinal products containing erythromycin or metronidazole,<br />aminoglycosides, other antibiotics or corticosteroids or if you are receiving<br />neuro- muscular blocking medicines e.g muscle relaxants used in anaesthesia.<br />Warfarin or similar medicines used to thin the blood; you may be more likely<br />to have a bleed. Your doctor may need to take regular blood tests to check<br />how well your blood can clot.<br />Pregnancy, breast-feeding and fertility<br />If you are pregnant or breast-feeding, thinking you may be pregnant or are<br />planning to have a baby, ask your doctor or pharmacist for advice before<br />taking this medicine.<br />You should not use this medicine if you are pregnant, especially during the<br />first three months of the pregnancy, or if you are breastfeeding. It is not<br />known if Acretin C&trade; may harm your unborn baby or pass through your milk<br />and harm your baby.<br />If you are a woman of child-bearing age you should use contraception<br />while using this medicine and for one month after discontinuation of<br />treatment.<br />Driving and using machines<br />Acretin C&trade; is unlikely to have an effect on the ability to drive or operate<br />machines.<br />Important information about some of the ingredients of Acretin C&trade; gel<br />Acretin C&trade; contains Propylene glycol and Butyl hydroxytoluene which<br />may cause local skin reactions (e.g. contact dermatitis), or irritation to the eyes<br />and mucous membranes.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use this medicine exactly as your doctor has told you. Check with<br />your doctor or pharmacist if you are not sure.<br />The recommended dose is:<br />A pea-sized amount of Acretin C&trade; should be applied once daily at bedtime.<br />Method of administration<br />Wash your face gently with mild soap and warm water and pat your skin dry<br />with a towel. Squeeze a pea-sized amount of gel onto the fingertip. Dab the<br />gel on your forehead, chin, nose and both cheeks, and then gently spread it<br />evenly over your whole face.<br />Do not use more than the amount that has been suggested by your doctor, or<br />apply the product more frequently than instructed. Too much medication may<br />irritate the skin, and will not give faster or better results.<br />Duration of treatment<br />To get the best results with Acretin C&trade;, it is necessary to use it properly and<br />not stop using it as soon as your acne starts to get better. Typically, it may<br />take several weeks to have an optimal effect. In some cases, it may take up to<br />12 weeks. Please contact your doctor if symptoms persist for more than 12<br />weeks, as your doctor will need to re-evaluate your treatment.</p><p>If you use more Acretin C&trade; than you should<br />You will not get faster or better results by using more Acretin C&trade; than<br />recommended. If you use too much a marked redness, peeling, or discomfort<br />may occur. In such cases, the face should be gently washed with a mild soap<br />and lukewarm water. The use of this medicine should be stopped until all<br />these symptoms have gone away.<br />Overdose may also result in side effects from your stomach and intenstine;<br />including stomach pain, nausea, vomiting and diarrhoea. In such cases, the use<br />of this medicine should be discontinued and your doctor should be contacted.<br />Acretin C&trade; is only for use on the skin. In case of accidental ingestion, contact<br />your doctor or go to the nearest hospital casualty department immediately.<br />If you forget to use Acretin C&trade;<br />If you forget to use Acretin C&trade; at bedtime, you should apply the next dose at<br />the usual time. You should not double the dose to make up for the forgotten<br />dose.<br />If you have any further questions on the use of this product, ask your doctor or<br />pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not<br />everybody gets them.<br />Uncommon: may affect up to 1 in 100 people<br />&bull; Acne, dry skin, redness of the skin, increased sebum production,<br />photosensitivity reaction, itching, rash, scaly rash, scaling of the skin, sunburn<br />&bull; Application site reactions such as burning, inflamed skin, dryness, redness of<br />the skin<br />Rare: may affect up to 1 in 1,000 people<br />&bull; Hypersensitivity<br />&bull; Underactive thyroid gland (symptoms may include fatigue, weakness,<br />weight gain, dry hair, rough pale skin, hair loss, increased sensitivity to cold).<br />&bull; Headache<br />&bull; Eye irritation<br />&bull; Gastroenteritis (inflammation of any part of the gastro- intestinal tract),<br />nausea<br />&bull; Inflamed skin, herpes simplex (cold sore), macular rash (small, flat, red<br />spots), skin bleeding, skin burning sensa- tion, loss of skin pigmentation, skin<br />irritation<br />&bull; Application site symptoms such as irritation, swelling, superficial skin<br />damage, discolouration, itching, scaling<br />&bull; Feeling hot, pain<br />Reporting of side effects<br />If you get any side effects, talk to your doctor or pharmacist. This includes<br />any possible side effects not listed in this leaflet. By reporting side effects you<br />can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the sight and reach of children.<br />Do not store above 30 &deg;C.<br />Keep the tube tightly closed.<br />Do not use this medicine after the expiry date which is stated on the carton<br />and tube after &ldquo;EXP&rdquo;.<br />Discard the tube after 3 months from opening.<br />Do not throw away any medicines via wastewater or household waste. Ask<br />your pharmacist how to throw away medicines you no longer use. These<br />measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Acretin C&trade; Gel contains:<br />The active substance in Acretin C&trade; are Clindamycin Phosphate 1.2% and<br />Tretinoin 0.025%.<br />The other Ingredients are: Edetate Disodium (EDTA), Butylated<br />Hydroxytoluene, Citric Acid Monohydrate, Propylene Glycol, Methylparaben,<br />Laureth-4, Carbopol 980 NF, (Carbomer &ndash; Type C), Tromethamine (Tris<br />Amino) and Purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Acretin C™ Gel is Yellow, Opaque topical gel free from grits or lumps.
Acretin C™ Gel comes in 30 g aluminum collapsible tube
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorisation Holder and Manufacturer<br />Jamjoom Pharmaceuticals Co., Jeddah, Saudi Arabia.<br />Tel: +966-12-6081111, Fax: +966-12-6081222.<br />Website: www.jamjoompharma.com<br />To report any side effect(s):<br />&bull; Saudi Arabia:<br />- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222,<br />Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States:<br />&minus; Please contact the relevant competent authority.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                22-04-2019
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>۱. ما ھو أكرتین سي<br />جل على المواد الفعالة كلیندامیسین فوسفات وتریتینوین. كلیندامیسین فوسفات ھو &trade; یحتوي أكرتین سي<br />عبارة عن مضاد حیوي. حیث یَحدُ من نمو البكتیریا المصاحبة لحب الشباب والالتھابات الناجمة عن<br />ھذه البكتیریا.<br />ا، كما أنھ یؤدي إلى معالجة الخلایا 􀌒 یجعل تریتینوین معدل نمو خلایا الجلد السطحیة معدلًا طبیعی<br />المسدودة بمسام الشعر في المنطقة المصابة بحب الشباب. ویمنع ذلك تراكم الزیوت التي تفرزھا<br />الغدد الدھنیة، وتكوُّن إصابات مبكرة ناجمة من حب الشباب (رؤوس سوداء وبیضاء)<br />تُظھر ھاتین المادتین الفعالتین فعالیة أكبر عند الاستخدام مع بعضھما عن استخدام كل منھما منفردًا.<br />جل على الجلد لعلاج حب الشباب لدى المرضى البالغین من العمر ۱۲ عامًا أو &trade; یُستخدم أكرتین سي<br />أكبر</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull; إذا كنت تُعاني من حساسیة تجاه كلیندامیسین أو تریتینوین أو أيِّ مكون من المكونات الأخرى الداخلة<br />.( في تركیب ھذا الدواء (المُدرجة في قسم ٦<br />&bull; إذا كنت تعاني من حساسیة تجاه لینكومیسین.<br />&bull; إذا كنت مصابًا بالتھاب مزمن في الأمعاء (مثل: مرض كرون أو التھاب القولون التقرحي).<br />ا من الاصابة بالتھاب القولون الذي تم معالجتھ في السابق بالمضادات 􀌒 &bull; إذا كان لدیك تاریخًا مرضی<br />الحیویة والذي یُمیز بإسھال مستمر أو شدید أو تقلصات في البطن.<br />&bull; إذا سبق أن عانیت أنت أو أحد أفراد الأسرة من سرطان الجلد.<br />&bull; إذا كنت تعاني من إكزیما حادة والتي تُمَیز بالتھاب الجلد واحمراره وجفافھ وتقشره.<br />&bull; إذا كنت تعاني من العد الوردي (حب الشباب الوردي)، وھو مرض جلدي یصیب الوجھ ویُمیز<br />بحدوث احمرار وظھور بثور وتقشر الجلد.<br />&bull; إذا كنت تعاني من حالات التھابات حادة أخرى بالجلد (مثل، التھاب المسام)، خاصة حول الفم<br />(التھاب الجلد المحیط بالفم).<br />&bull; إذا كنت تعاني من أشكال معینة خاصة لحب الشباب، والتي تتمیز بحبوب عقدیة كیسیة عمیقة وبثریة<br />(حب شباب مُكبب وحب شباب خاطف).<br />إذا انطبق علیك أي مما سبق، لا تستخدم ھذا الدواء واستشر طبیبك.<br />تحذیرات واحتیاطات<br />&bull; تجنب أن یلمس ھذا الدواء الفم أو العینین أو الأغشیة المخاطیة أو البشرة المصابة بإكزیما أو خدوش.<br />كن حذرًا أثناء وضع ھذا الدواء على جلد المناطق الحساسة. في حالة لمس ھذا الدواء للعینین، اغسل<br />عینیك بكمیة كبیرة من الماء الفاتر.<br />أثناء الحمل، وعلى وجھ التحدید خلال الأشھر الثلاث الأولى من &trade; &bull; یجب ألا تستخدمي أكرتین سي<br />إلا إذا كنتِ تستخدمین &trade; الحمل. إذا كنتِ سیدة قادرة على الحمل، علیكِ تجنب استخدام أكرتین سي<br />وسائل منع حمل (انظري قسم &quot;الحمل والرضاعة الطبیعیة والخصوبة&quot;).<br />&bull; توقف عن استخدام الدواء واستشر الطبیب المعالج لك على الفور إذا أصبت بإسھال مستمر أو شدید<br />أو تقلصات في البطن.<br />&bull; یُرجى استشارة الطبیب المعالج لك قبل استخدام ھذا الدوار إذا كنت مصابًا بإكزیما تأتبیة (التھاب<br />مزمن في الجلد یثیر الحكة).<br />&bull; یجب تجنب التعرض للضوء الطبیعي أو الصناعي (مثل المصباح الكھربائي). لأن ھذا الدواء یجعل<br />بشرتك أكثر حساسیة للتعرض لحروق الشمس والآثار الجانبیة الأخرى للشمس.<br />&bull; یجب استخدام واقي من الشمس ذو عامل وقایة من الشمس لا یقل عن ۳۰ ، بالإضافة إلى ملابس<br />واقیة (مثل القبعة) كلما خرجت إلى أشعة الشمس.<br />&bull; إذا تعرض وجھك لحروق الشمس بالرغم من استخدامك لواقٍ، توقف عن استخدام الدواء حتى<br />تتحسن بشرتك.<br />&bull; استشر طبیبك في حالة الإصابة بالتھاب حاد في الجلد أُثناء استخدام ھذا الدواء.<br />عند استخدام مستحضرات دوائیة أخرة على الجلد في نفس الوقت، بما &trade; &bull; یُحظر استخدام أكرتین سي<br />.(&quot; &trade; فیھا مستحضرات التجمیل (انظر قسم &quot;استخدام أدویة أخرى مع أكرتین سي&nbsp;</p><p>استخدام أدویة أخرى مع أكرتین سي<br />أخبر الطبیب المعالج لك أو الصیدلي الخاص بك إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي<br />أدویة أخرى. یتضمن ذلك الأدویة التي حصلت علیھا دون وصفة طبیة والأدویة العشبیة. ھذا لأن<br />قد یُؤثر على طریقة عمل بعض الأدویة الأخرى. وبالمثل، فقد تُؤثر بعض الأدویة &trade; أكرتین سي<br />.&trade; الأخرى على آلیة عمل أكرتین سي<br />إذا استخدمت أي مستحضر دوائي یحتوي على كبریت أو حمض سالسیلیك أو بیزویل بیروكسید أو<br />ریزورسینول أو أي كیماویات كاشطة أخرى، سوف یتعین علیك الانتظار حتى یزول مفعول ھذه<br />&trade; المواد لكي تستطیع استخدام ھذا الدواء. سیخبرك الطبیب المعالج لك بموعد استخدام أكرتین سي<br />وكیفیة القیام بھذا.<br />یُحظر استخدام أنواع صابون طبیة منظفة أو مواد تقشیر الوجھ التي لھا تأثیر مُجفِّف قوي خلال العلاج<br />یجب توخي الحذر أثناء استخدام المواد التالیة والتي قد یكون لھا تأثیر مُجفِّف: أنواع .&trade; بأكرتین سي<br />الصابون المنظفة والصابون ومستحضرات التجمیل والمواد ذات التركیز المرتفع من الكحول والأدویة<br />القابضة والتوابل واللیمون.<br />علیك استشارة الطبیب المعالج لك قبل استخدام ھذا الدواء مع المستحضرات الدوائیة الأخرى التي<br />تحتوي على إریثرومیسین أو میترونیدازول أو أمینوجلیكوزیدات أو مضادات حیویة أو<br />كورتیكوستیرویدات أخرى أو إذا كنت تستخدم أدویة حاصرة عضلیة عصبیة مثل مرخیات العضلات<br />المستخدمة في المخدرات. قد تكون أكثر عُرضة للنزف في حالة استخدام وارفارین أو الأدویة الأخرى<br />التي تسبب ترقق الدم. قد یحتاج الطبیب المعالج لك إلى إجراء اختبارات دم دوریة لك للتحقق من مدى<br />قابلیة دمك للتجلط.<br />الحمل والرضاعة الطبیعیة والخصوبة<br />إذا كنتِ حاملًا أو مرضعةً أو تعتقدین أنكِ حامل أو تخططین لذلك، فاستشیري الطبیب المتابع لكِ أو<br />الصیدلي الخاص بكِ قبل تناوُل ھذا الدَّواء.<br />یجب ألا تستخدمي ھذا الدواء أثناء الحمل، وعلى وجھ الخصوص خلال الأشھر الثلاث الأولى من<br />یضر &trade; الحمل أو إذا كنتِ تمارسین الإرضاع الطبیعي. ومن غیر المعروف ما إذا كان أكرتین سي<br />الجنین أو یمر إلى لبن الأم ویضر رضیعك أم لا.<br />إذا كنت امرأة في سن الإنجاب ، فیجب علیك استخدام وسائل منع الحمل أثناء استخدام ھذا الدواء و<br />لمدة شھر واحد بعد التوقف عن العلاج.<br />القیادة واستخدام الآلات<br />غالبًا في القدرة على القیادة أو استخدام الآلات. &trade; لا یؤثر أكرتین سي<br />جل &trade; معلومات ھامة حول بعض مكونات أكرتین سي<br />جل على بروبیلین جلیكول و بوتیل ھیدروكسي التولین وھما مادتین قد یسببا &trade; یحتوي أكرتین سي<br />تفاعلات حساسیة موضعیة (مثل: التھاب الجلد موضع اللمس)، أو تھیج العینین والأغشیة المخاطیة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>استخدم دائمًا ھذا الدَّواء كما أخبرك الطبیب المعالج لك بالضبط. یُرجى مراجعة الطبیب أو الصیدلي<br />الخاص بك إذا لم تكن متأكدًا.<br />الجُرعة المُوصى بھا ھي:<br />ا قبل النوم. 􀌒 مرة واحدة یومی &trade; یجب وضع كمیة بحجم حبة البازلاء من أكرتین سي<br />طریقة الاستخدام<br />اغسل وجھك برفق بصابون طفیف التأثیر وماء دافئ، ثم نشف وجھك بالمنشفة لتجفیفھ. أخرج كمیة<br />من الجل بحجم حبة بازلاء على طرف إصبع، وضع أجزاء من الجل على جبھتك وذقنك وأنفك<br />وخدیك، ثم وزعھم برفق بالتساوي على وجھك بأكملھ.<br />لا تستخدم كمیة أكبر من تلك التي وصفھا الطبیب المعالج لك ولا تستخدم مستحضر دوائي عدد مرات<br />أكثر مما ورد في التعلیمات. حیث أن استخدام كمیة كبیرة من الدواء قد تؤدي إلى تھیج البشرة ولن<br />تُظھر نتائج سریعة أو تحسن.<br />مدة العلاج<br />لا بد من أن تستخدمھ بشكل صحیح ولا توقف ،&trade; لكي تحصل على أفضل نتیجة من أكرتین سي<br />استخدامھ بمجرد بدء تحسن حالة حب الشباب التي تعاني منھا. عادة ما یستغرق العلاج عدة أسابیع لكي<br />یُعطي أفضل نتیجة. وقد یستغرق ما یصل إلى ۱۲ أسبوع في بعض الحالات. یُرجى الاتصال بالطبیب<br />المعالج لك إذا استمرت أعراض المرض لما یزید عن ۱۲ أسبوع، حیث سیحتاج الطبیب المعالج لك<br />إلى إعادة تقییم علاجك.</p><p>إذا استخدمت كمیة أكثر مما یجب من أكرتین سي<br />أكثر من تلك الكمیة &trade; لن تحصل على نتائج أفضل أو أسرع عندما تستخدم كمیة من أكرتین سي<br />الموصى بھا. قد یحدث احمرار وتقشر وعدم راحة إذا استخدمت كمیة أكثر مما ینبغي. وفي مثل ھذه<br />الحالات، یجب غسل الوجھ برفق بصابون خفیف التأثیر وماء فاتر دافئ. یجب إیقاف استخدام ھذا<br />الدواء حتى تزول ھذه الأعراض تمامًا.<br />قد یؤدي استخدام جرعة زائدة إلى حدوث أعراض جانبیة في المعدة والأمعاء، وتشمل ھذه<br />الأعراض ألم بالمعدة وغثیان وقيء وإسھال. في ھذه الحالة، یجب إیقاف استخدام ھذا الدواء<br />مُخصص للاستخدام على البشرة. أخبر الطبیب &trade; والاتصال بالطبیب المعالج لك. یعتبر أكرتین سي<br />المعالج لك أو اذھب فورًا إلى قسم الطوارئ بأقرب مستشفى إذا تناولت ھذا الدواء عن طریق الخطأ.<br />&trade; إذا نسیت استخدام أكرتین سي<br />قبل النوم مباشرة، ضع الجرعة التالیة في وقتھا المحدد، ولا تستخدم &trade; إذا نسیت استخدام أكرتین سي<br />جرعة مضاعفة لتعویض الجرعة التي أغفلتھا.<br />إذا كان لدیك أیة أسئلة إضافیة حول استخدام ھذا المستحضر، فاستشر الطبیب المعالج لك أو<br />الصیدلي الخاص بك.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثلھ مثل كافة الأدویة، قد یُسبب ھذا الدواء آثارًا جانبیة، على الرغم من عدم حدوثھا للجمیع.<br />غیر شائعة: قد تُؤثر على ما یصل إلى مریض واحد من بین كل ۱۰۰ مریض<br />&bull; حب شباب، جفاف الجلد، احمرار الجلد، زیادة إفراز الغدد الدھنیة، حساسیة تجاه الضوء، حكة،<br />طفح جلدي، تقشر الجلد، حروق شمس<br />&bull; تفاعلات في موضع الاستخدام مثل حرق والتھاب الجلد وجفاف واحمرار الجلد<br />نادرة: قد تُؤثر على ما یصل إلى ۱ من بین كل ۱,۰۰۰ شخص<br />&bull; فرط الحساسیة<br />&bull; ضعف نشاط الغدة الدرقیة (قد تتضمن الأعراض: تعب، ضعف، زیادة الوزن، جفاف الشعر،<br />تقشر شدید في الجلد، تساقط الشعر، زیادة الحساسیة تجاه البرد).<br />&bull; صداع<br />&bull; تھیُّج العین<br />&bull; التھاب المعدة والأمعاء (التھاب أي جزء من الجھاز الھضمي)، غثیان<br />&bull; التھاب الجلد، ھربس بسیط (قرح البرد)، طفح بقعي (بقع صغیرة مفلطحة حمراء)، نزف الجلد،<br />احساس بالحرق في الجلد، فقدان تصبغ الجلد، تھیج الجلد<br />&bull; أعراض في موضع الاستخدام، مثل: تھیج، تورم، إصابات سطحیة على الجلد، تغیر لون الجلد،<br />حكة، تقشر<br />&bull; الشعور بازدیاد الحرارة، ألم<br />الإبلاغ عن الآثار الجانبیة<br />إذا ظھرت لدیك أیَّة آثار جانبیة، فتحدَّث إلى الطبیب المعالج لك أو الصیدلي الخاص بك. یشمل ذلك<br />أیة آثار جانبیة مُحتمَلة، غیر المُدرجة في ھذه النَّشرة. من خلال إبلاغك عن الآثار الجانبیة، یمكنك<br />المساعدة في توفیر معلومات إضافیة حول أمان استخدام ھذا الدَّواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>یُحفظ بعیدًا عن مرأى ومتناول الأطفال.<br />یحفظ في درجة حرارة لا تزید عن ۳۰ درجة مئویة.<br />یحفظ الأنبوب مغلقًا بإحكام.<br />.&quot;EXP&quot; لا تستعمل ھذا الدَّواء بعد تاریخ انتھاء الصلاحیة المدون على العبوة والأنبوب بعد كلمة<br />تخلص من الأنبوبة بعد ۳ أشھر من فتحھا.<br />لا تتخلص من الأدویة عن طریق إلقائھا في میاه الصرف أو مع المخلفات المنزلیة. استشر الصیدلي<br />الخاص بك عن كیفیة التَّخلص من الأدویة التي لم تعد تستخدمھا. ستساعد تلك الإجراءات على<br />حمایة البیئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ما ھي محتویات أكرتین سي<br />جل ھي ۱٫۲ ٪ كلیندامیسین فوسفات و ۰٫۰۲٥ ٪ ترتینوین. &trade; المواد الفعالة في أكرتین سي<br />المكونات الأخرى:<br />بیوتیل ھیدروكسي تولوین، حمض ستریك أحادي الھیدرات، ،(EDTA) إیدیتات ثنائیة الصودیوم<br />كربومیر (نوع سي)، ،NF جلیكول البروبیلین، میثیل بارابین، لوریث ٤، كاربوبول ۹۸۰<br />ترومیثامین (تریس أمینو) و ماء منقى.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>ما ھو شكل أكرتین سي<br />جل عبارة عن جل موضعي أصفر غیر شفاف خالي من الحبیبات أو الكتل. &trade; أكرتین سي<br />جل فى انبوبة من الألومینیوم ۳۰ جرام. &trade; یتوفر أكرتین سي</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>اسم وعنوان مالك رخصة التسویق و المصنع:<br />شركة مصنع جمجوم للأدویة، جدة، المملكة العربیة السعودیة.<br />+۹٦٦-۱۲- ۹٦٦ + فاكس: ٦۰۸۱۲۲۲ -۱۲- ھاتف: ٦۰۸۱۱۱۱<br />www.jamjoompharma.com : الموقع الإلكتروني<br />للإبلاغ عن أي أثار جانبیھ:<br />&bull; المملكة العربیة السعودیة:<br />- المركز الوطني للتیقظ و السلامة الدوائیة<br />+۹٦٦-۱۱-۲۰٥- فاكس: ۷٦٦۲ o<br />للإتصال بالإدارة التنفیذیة للتیقظ وإدارة الأزمات. o<br />+۹٦٦-۱۱- ھاتف: ۲۰۳۸۲۲۲<br />۲۳٤۰-۲۳۳٤-۲۳٥٤-۲۳٥۳-۲۳٥٦- تحویلة: ۲۳۱۷<br />الھاتف المجاني: ۸۰۰۲٤۹۰۰۰۰ o<br />npc.drug@sfda.gov.sa : برید إلكتروني o<br />www.sfda.gov.sa/npc : الموقع الالكتروني</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            22-04-2019
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Acretin C 1.2% & 0.025% Gel
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each gram of gel contains 12.00 mg (1.2%) clindamycin (as clindamycin phosphate) and 0.250 mg
(0.025%) tretinoin.
Excipients with known effect:
 Methylparaben
 Butylated Hydroxytoluene
For the full list of excipients, see section 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Topical Gel, Acretin C is yellow, opaque topical gel free from grits or lumps filled in 30 g aluminum
collapsible tubes .
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acretin C (Clindamycin phosphate and Tretinoin) Gel, 1.2%/0.025% is indicated for the topical<br />treatment of acne vulgaris in patients 12 years and older.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />Clindamycin Phosphate &amp; Tretinoin Gel should be applied once daily in the evening, gently rubbing<br />the medication to lightly cover the entire affected area. Approximately a pea-sized amount will be<br />needed for each application. Avoid the eyes, lips, and mucous membranes.<br />Clindamycin Phosphate &amp; Tretinoin Gel is not for oral, ophthalmic, or intravaginal use.<br />Method of administration<br /> At bedtime, the face should be gently washed with a mild soap and water. After patting the skin<br />dry, apply Clindamycin Phosphate &amp; Tretinoin Gel as a thin layer over the entire affected area<br />(excluding the eyes and lips).</p><p> Patients should be advised not to use more than a pea-sized amount to cover the face and not to<br />apply more often than once daily (at bedtime) as this will not make for faster results and may<br />increase irritation.<br /> A sunscreen should be applied every morning and reapplied over the course of the day as<br />needed. Patients should be advised to avoid exposure to sunlight, sunlamp, ultraviolet light,<br />and other medicines that may increase sensitivity to sunlight.<br /> Other topical products with a strong drying effect such as abrasive soaps or cleansers may<br />cause an increase in skin irritation with Clindamycin Phosphate &amp; Tretinoin Gel.<br />Skin Irritation<br />Clindamycin Phosphate &amp; Tretinoin Gel may cause irritation such as erythema, scaling,<br />itching, burning, or stinging<br />Colitis<br />In the event a patient treated with Clindamycin Phosphate &amp; Tretinoin Gel experiences severe<br />diarrhea or gastrointestinal discomfort, Clindamycin Phosphate &amp; Tretinoin Gel should be<br />discontinued and a physician should be contacted.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Acretin C is contraindicated:
• In patients who have a history of hypersensitivity to the active substances clindamycin and/or
tretinoin or to any of the excipients or lincomycin (see also Section 6.1)
• In patients with regional enteritis, ulcerative colitis, or history of antibiotic-associated colitis
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Colitis<br />Systemic absorption of clindamycin has been demonstrated following topical use.<br />Diarrhea, bloody diarrhea, and colitis (including pseudomembranous colitis) have been reported<br />with the use of topical clindamycin. If significant diarrhea occurs, Clindamycin Phosphate &amp;<br />Tretinoin Gel should be discontinued.<br />Severe colitis has occurred following oral or parenteral administration of clindamycin with an<br />onset of up to several weeks following cessation of therapy. Antiperistaltic agents such as opiates<br />and diphenoxylate with atropine may prolong and/or worsen severe colitis. Severe colitis may result<br />in death.<br />Studies indicate a toxin(s) produced by clostridia is one primary cause of antibiotic-associated<br />colitis. The colitis is usually characterized by severe persistent diarrhea and severe abdominal</p><p>cramps and may be associated with the passage of blood and mucus. Stool cultures for Clostridium<br />difficile and stool assay for C. difficile toxin may be helpful diagnostically.<br />Ultraviolet Light and Environmental Exposure<br />Exposure to sunlight, including sunlamps, should be avoided during the use of Clindamycin Phosphate<br />&amp; Tretinoin Gel.<br />Patients with sunburn should be advised not to use the product until fully recovered because of<br />heightened susceptibility to sunlight as a result of the use of tretinoin. Patients who may be required to<br />have considerable sun exposure due to occupation and those with inherent sensitivity to the sun should<br />exercise particular caution. Daily use of sunscreen products and protective apparel (e.g., a hat) are<br />recommended. Weather extremes, such as wind or cold, also may be irritating to patients under treatment<br />with Clindamycin Phosphate &amp; Tretinoin Gel.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clindamycin Phosphate &amp; Tretinoin Gel should not be used in combination with erythromycincontaining<br />products due to possible antagonism to the clindamycin component. In vitro studies have<br />shown antagonism between these 2 antimicrobials. The clinical significance of this in vitro antagonism<br />is not known.<br />Neuromuscular Blocking Agents<br />Clindamycin has been shown to have neuromuscular blocking properties that may enhance the action of<br />other neuromuscular blocking agents. Therefore, Clindamycin Phosphate &amp; Tretinoin Gel should be<br />used with caution in patients receiving such agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />Pregnancy Category C.<br />There are no well-controlled studies in pregnant women treated with Clindamycin Phosphate &amp;<br />Tretinoin gel. Clindamycin Phosphate &amp; Tretinoin Gel should be used during pregnancy only if the<br />potential benefit justifies the potential risk to the fetus. A limit teratology study performed in Sprague<br />Dawley rats treated topically with Clindamycin Phosphate &amp; Tretinoin Gel or 0.025% tretinoin gel at a<br />dose of 2 mL/kg during gestation days 6 to 15 did not result in teratogenic effects. Although no systemic<br />levels of tretinoin were detected, craniofacial and heart abnormalities were described in drug-treated<br />groups. These abnormalities are consistent with retinoid effects and occurred at 16 times the</p><p>recommended clinical dose assuming 100% absorption and based on body surface area comparison. For<br />purposes of comparison of the animal exposure to human exposure, the recommended clinical dose is<br />defined as 1g of Clindamycin Phosphate &amp; Tretinoin Gel applied daily to a 50-kg person.<br />Clindamycin: Reproductive developmental toxicity studies performed in rats and mice using oral doses<br />of clindamycin up to 600 mg/kg/day (480 and 240 times the recommended clinical dose based on body<br />surface area comparison, respectively)<br />or subcutaneous doses of clindamycin up to 180 mg/kg/day (140 and 70 times the recommended clinical<br />dose based on body surface area comparison, respectively) revealed no evidence of teratogenicity.<br />Tretinoin: Oral tretinoin has been shown to be teratogenic in mice, rats, hamsters, rabbits, and primates.<br />It was teratogenic and fetotoxic in Wistar rats when given orally at doses greater than 1 mg/kg/day (32<br />times the recommended clinical dose based on body surface area comparison). However, variations in<br />teratogenic doses among various strains of rats have been reported. In the cynomologous monkey, a<br />species in which tretinoin metabolism is closer to humans than in other species examined, fetal<br />malformations were reported at oral doses of 10 mg/kg/day or greater, but none were observed at 5<br />mg/kg/day (324 times the recommended clinical dose based on body surface area comparison), although<br />increased skeletal variations were observed at all doses. Dose-related teratogenic effects and increased<br />abortion rates were reported in pigtail macaques. With widespread use of any drug, a small number of<br />birth defect reports associated temporally with the administration of the drug would be expected by<br />chance alone. Thirty cases of temporally associated congenital malformations have been reported<br />during 2 decades of clinical use of another formulation of topical tretinoin. Although no definite pattern<br />of teratogenicity and no causal association have been established from these cases, 5 of the reports<br />describe the rare birth defect category, holoprosencephaly (defects associated with incomplete midline<br />development of the forebrain). The significance of these spontaneous reports in terms of risk to fetus is<br />not known.<br />Nursing Mothers<br />It is not known whether clindamycin is excreted in human milk following use of Clindamycin Phosphate<br />&amp; Tretinoin Gel. However, orally and parenterally administered clindamycin has been reported to appear<br />in breast milk. Because of the potential for serious adverse reactions in nursing infants, a decision should<br />be made whether to discontinue nursing or to discontinue the drug, taking into account the importance<br />of the drug to the mother. It is not known whether tretinoin is excreted in human milk. Because many<br />drugs are excreted in human milk, caution should be exercised when Clindamycin Phosphate &amp;<br />Tretinoin Gel is administered to a nursing woman.</p><p>Pediatric Use<br />Safety and effectiveness of Clindamycin Phosphate &amp; Tretinoin Gel in pediatric patients younger than<br />12 years have not been established.<br />Clinical trials of Clindamycin Phosphate &amp; Tretinoin Gel included 2,086 subjects aged 12 through 17<br />years with acne vulgaris. [See Clinical Studies (14).]<br />Geriatric Use<br />Clinical trials of Clindamycin Phosphate &amp; Tretinoin Gel did not include sufficient numbers of<br />subjects aged 65 and older to determine whether they respond differently from younger subjects.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed. It is unlikely<br />that treatment with Acretin C will have any effect on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse Reactions in Clinical Trials<br />Because clinical trials are conducted under widely varying conditions, adverse reaction rates<br />observed in clinical trials of a drug cannot be directly compared with rates in the clinical trials<br />of another drug and may not reflect the rates observed in clinical practice.<br />The safety data reflect exposure to Clindamycin Phosphate &amp; Tretinoin Gel in 1,104 subjects with<br />acne vulgaris.<br />Subjects were 12 years and older and were treated once daily in the evening for 12 weeks.<br />Adverse reactions that were reported in &ge;1% of subjects treated with Clindamycin Phosphate &amp;<br />Tretinoin Gel are presented in Table 1.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acretin C Gel is for topical use only. If Acretin C Gel is applied excessively, marked redness, peeling<br />or discomfort can occur. If excess application occurs accidentally or through over-enthusiastic use,<br />the face should be gently washed with a mild soap and lukewarm water. Acretin C should be<br />discontinued for several days before resuming therapy.<br />In the case of overdosage, topically applied clindamycin phosphate from Acretin C can be absorbed<br />in sufficient amounts to cause systemic effects. Gastrointestinal side effects including abdominal<br />pain, nausea, vomiting and diarrhoea may occur (see section 4.4)<br />In the event of accidental ingestion, treatment should be symptomatic. The same adverse reactions<br />effects as those expected with clindamycin (i.e. abdominal pain, nausea, vomiting and diarrhoea) and<br />tretinoin (including teratogenesis in women of childbearing years) are expected. In such cases,<br />Acretin C Gel should be discontinued and pregnancy testing should be carried out in women of<br />childbearing potential.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Anti-Acne Preparations for Topical Use; clindamycin, combinations<br />ATC code: D10AF51<br />Acretin C combines two active substances, which act through different mechanisms of action (see<br />below).<br />Clindamycin:<br />Mechanism of Action: Clindamycin binds to the 50S ribosomal subunit of susceptible bacteria and<br />prevents elongation of peptide chains by interfering with peptidyl transfer, thereby suppressing<br />proteinsynthesis. Clindamycin has been shown to have in vitro activity against Propionibacterium acnes<br />(P. acnes), an organism that has been associated with acne vulgaris; however, the clinical significance of<br />this activity against P. acnes was not examined in clinical trials with Clindamycin Phosphate &amp; Tretinoin<br />Gel. P. acnes resistance to clindamycin has been documented.<br />Inducible Clindamycin Resistance: The treatment of acne with antimicrobials is associated<br />with the development of antimicrobial resistance in P. acnes as well as other bacteria (e.g., Staphylococcus<br />aureus, Streptococcus pyogenes). The use of clindamycin may result in developing inducible resistance<br />in these organisms. This resistance is not detected by routine susceptibility testing.<br />Cross Resistance: Resistance to clindamycin is often associated with resistance<br />to erythromycin.<br />Tretinoin:<br />Although the exact mode of action of tretinoin is unknown, current evidence suggests that topical<br />tretinoin decreases cohesiveness of folliculare epithelial cells with decreased microcomedone<br />formation. Additionally, tretinoin stimulates mitotic activity and increased turnover of follicular<br />epithelial cells causing extrusion of the comedones.<br />Nonclinical Toxicology<br />Carcinogenesis, Mutagenesis, Impairment of Fertility<br />Long-term animal studies have not been performed to evaluate the carcinogenic potential of Clindamycin<br />Phosphate &amp; Tretinoin Gel or the effect of Clindamycin Phosphate &amp; Tretinoin gel on fertility.<br />Clindamycin Phosphate &amp; Tretinoin gel was negative for mutagenic potential when evaluated in an in<br />vitro ames salmonella reversion assay. Clindamycin Phosphate &amp; Tretinoin Gel was equivocal for<br />clastogenic potential in the absence of metabolic activation when tested in an in vitro chromosomal<br />aberration assay.<br />Clindamycin: Once-daily dermal administration of 1% Clindamycin as Clindamycin phosphate<br />in the gel vehicle (32 mg/kg/day, 13 times the recommended clinical dose based on body surface area<br />comparison) to mice for up to 2 years did not produce evidence of tumorigenicity.</p><p>Fertility studies in rats treated orally with up to 300 mg/kg/day of clindamycin (240 times the<br />recommended clinical dose based on body surface area comparison) revealed no effects on fertility or<br />mating ability.<br />Tretinoin: In 2 independent mouse studies where tretinoin was administered topically (0.025% or 0.1%)<br />3 times per week for up to 2 years no carcinogenicity was observed, with maximum effects of dermal<br />amyloidosis. However, in a dermal carcinogenicity study in mice, tretinoin applied at a dose of 5.1 mcg<br />(1.4 times the recommended clinical dose based on body surface area comparison) 3 times per week for<br />20 weeks acted as a weak promoter of skin tumor formation following a single application of<br />dimethylbenz[&alpha;] anthracene (DMBA).<br />In a study in female SENCAR mice, papillomas were induced by topical exposure to DMBA followed by<br />promotion with 12-O-tetradecanoylphorbol-13-acetate or mezerein for up to 20 weeks. Topical<br />application of tretinoin prior to each application of promoting agent resulted in a reduction in the number<br />of papillomas per mouse. However, papillomas resistant to topical tretinoin suppression were at higher<br />risk for pre-malignant progression.<br />Tretinoin has been shown to enhance photocarcinogenicity in properly performed specific studies,<br />employing concurrent or intercurrent exposure to tretinoin and UV radiation. The photocarcinogenic<br />potential of the clindamycin tretinoin combination is unknown.<br />Although the significance of these studies to humans is not clear, patients should avoid exposure to sun.<br />The genotoxic potential of tretinoin was evaluated in an in vitro Ames Salmonella reversion<br />test and an in vitro chromosomal aberration assay in Chinese hamster ovary cells. Both tests were negative.<br />In oral fertility studies in rats treated with tretinoin, the no-observed-effect-level was 2 mg/<br />kg/day (64 times the recommended clinical dose based on body surface area comparison).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In an open-label trial of 17 subjects with moderate-to-severe acne vulgaris, topical administration of<br />approximately 3 grams of Clindamycin Phosphate &amp; Tretinoin Gel once daily for 5 days, clindamycin<br />concentrations were quantifiable in all 17 subjects starting from 1 hour post-dose. All plasma clindamycin<br />concentrations were &le;5.56 ng/mL on Day 5, with the exception of 1 subject who had a maximum<br />clindamycin concentration of 8.73 ng/mL at 4 hours post-dose. There was no appreciable increase in<br />systemic exposure to tretinoin, as compared with the baseline value. The average tretinoin concentration<br />across all sampling times on Day 5 ranged from 1.19 to 1.23 ng/mL compared with the corresponding<br />baseline mean tretinoin concentration range of 1.16 to 1.30 ng/mL.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The safety and efficacy of Clindamycin Phosphate &amp; Tretinoin Gel, applied once daily for the treatment<br />of acne vulgaris,<br />was evaluated in 12-week multi-center, randomized, blinded trials in subjects 12 years<br />and older.<br />Treatment response was defined as the percent of subjects who had a 2-grade improvement<br />from baseline to Week 12 based on the Investigator&rsquo;s Global Assessment (IGA) and a mean<br />absolute change from baseline to Week 12 in 2 out of 3 (total, inflammatory, and<br />non-inflammatory) lesion counts. The IGA scoring scale used in all the clinical trials for<br />CLINDAMYCIN PHOSPHATE &amp; TRETINOIN Gel.</p><p>The safety and efficacy of clindamycin-tretinoin gel was also evaluated in 2 additional 12-week, multicentered,<br />randomized, blinded trials in subjects 12 years and older. A total of 2,219 subjects with mildto-<br />moderate acne vulgaris were treated once daily for 12 weeks. Of the 2,219 subjects, 634 subjects were<br />treated with clindamycin-tretinoin gel. These trials demonstrated consistent outcomes.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p> Edetate Disodium (EDTA)<br /> Butylated Hydroxytoulene<br /> Citric acid Monohydrate<br /> Propylene Glycol<br /> Methyl paraben<br /> Laureth-4<br /> Tromethamine (Tris Amino) USP<br /> Carbopol 980 NF (Carbomer Type-C)<br /> Purified water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Aluminium Collapsible Tubes 30 gm</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jamjoom Pharmaceuticals Company
Plot No. ME 1:3, Phase V, Industrial City, Jeddah
Postal address:
P.O. Box 6267
Jeddah 21442, Saudi Arabia.
Tel: 00966-12-6081111
Fax: 00966-12-6081222
E-mail: jpharma@jamjoompharma.com
Website: www.jamjoompharma.com
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                April-2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>